A new study found that overweight and obese people had a lower risk of death after developing dementia.

CHICAGO/SHANGHAI--Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects growth to accelerate significantly in 2025 as ...

New treatments that can slow the progression of Alzheimer's disease could provide significant lifetime benefits to patients and society, with even greater benefits when initiated earlier, according to ...

A qualitative study of eighteen family caregivers shows that palliative care consultations ease surrogate decision-making for hospitalized dementia patients, but insurance limits, service shortages, ...

People were about 19 percentage points less likely to recommend life-sustaining treatment for a seriously ill patient with ...

Agitation has a negative impact on the quality of life of patients with Alzheimer’s disease, according to 97% of their ...

Accounts raise tantalizing questions about what happens inside a brain afflicted by dementia and whether cognitive abilities ...

Alzheimer’s disease is a condition that affects the brain and slowly affects memory, thinking, and the ability to carry out ...

Atrial fibrillation (AF) is associated with major long-term complications, including ischaemic stroke and dementia. Over ...

Decades before the first symptoms of Alzheimer's disease appear, some changes associated with the disease may begin to leave ...